Educational program to reduce major bleeding in patients undergoing percutaneous coronary interventions and receiving abciximab

Am J Health Syst Pharm. 2002 Aug 15;59(16):1539-42. doi: 10.1093/ajhp/59.16.1539.
No abstract available

MeSH terms

  • Abciximab
  • Aged
  • Angioplasty, Balloon, Coronary*
  • Antibodies, Monoclonal / adverse effects*
  • Anticoagulants / adverse effects*
  • Female
  • Hemorrhage / chemically induced*
  • Hemorrhage / economics
  • Hemorrhage / prevention & control*
  • Heparin / adverse effects
  • Humans
  • Immunoglobulin Fab Fragments / adverse effects*
  • Male
  • Middle Aged
  • Patient Education as Topic*
  • Platelet Aggregation Inhibitors / adverse effects*
  • Retrospective Studies

Substances

  • Antibodies, Monoclonal
  • Anticoagulants
  • Immunoglobulin Fab Fragments
  • Platelet Aggregation Inhibitors
  • Heparin
  • Abciximab